GCAN.US Greater Cannabis Company Inc

Healthcare Pharmaceuticals USA Stocks
1.60 USD
Close of Nov 13, 2026
0.2565 2.50
Market cap
USD 318K
P/E
0.2x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is GCAN.US undervalued?

Graham number

The Graham number of Greater Cannabis Company Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Greater Cannabis Company Inc fundamental analysis

No fundamental analysis for Greater Cannabis Company Inc yet.

Greater Cannabis Company Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Greater Cannabis Company Inc

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

Full company profile